The WRONG statement of sumatriptan is that it -: (A) Is a selective 5- HT ID/IB receptor agonist, (B) Is safe for use in patients with epilepsy, (C) Suppresses neurogenic inflammation of cranial blood vessels, (D) Is useful in the treatment of an acute attack of migraine
Answer is B. Ans. is 'b' i.e., Is safe for use in patients with epilepsy o Contraindications of sumatriptan are ischaemic hea disease, hypeension, epilepsy, hepatic or renal impairment and during pregnancy.